Stephane Bancel, chief executive officer of Moderna Inc., during a Bloomberg Television interview on the closing day of the World Economic Forum (WEF) in Davos, Switzerland, on Thursday, May 26, 2022. The annual Davos gathering of political leaders, top executives and celebrities runs from May 22 to 26. Photographer: Jason Alden/Bloomberg via Getty Images
Moderna CEO Stephane Bancel during a Bloomberg Television interview on the closing day of the World Economic Forum in Davos, Switzerland, on May 26, 2022.

Lawmakers have already called Pfizer’s similar plan “pure and deadly greed.”

by Beth Mole

ARS Technica

January 11, 2022

Moderna is considering raising the price of its COVID-19 vaccine by over 400 percent—from $26 per dose to between $110 and $130 per dose—according to a report by The Wall Street Journal.

Ars has reached out to Moderna for comment but has not yet received a response. The plan, if realized, would match the previously announced price hike for Pfizer-BioNTech’s rival COVID-19 vaccine

The Journal spoke with Moderna CEO Stephane Bancel at the JP Morgan Healthcare Conference in San Francisco Monday, who said of the 400 percent price hike: “I would think this type of pricing is consistent with the value.”

Read More HERE

 

SHARE

LEAVE A REPLY